drugset / Trial / NCT00470418
Development of NIC5-15 in the Treatment of Alzheimer's Disease
Phase 2
Completed
15 enrolled
VA Office of Research and Development
Humanetics Corporation · collabNational Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of NIC5-15in the treatment of Alzheimer's Disease.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-08
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NIC5-15 | Small molecule | — | — |